Research in the Channing Division of Network Medicine (CDNM) focuses on identifying the causes of diseases and developing new biomarkers for prevention, diagnosis, progression, and therapeutic intervention.
CDNM’s research applies novel systems biology capabilities to vast clinical databases and research studies with genetic, clinical, and epidemiological information on more than 300,000 subjects.
CDNM currently has more than 80 Harvard Medical School (HMS) faculty and 42 fellows and is supported by 160 non-faculty Brigham and Women’s Hospital (BWH) employees, who are primarily in research and administration.
In fiscal year 2019, CDNM investigators received 54 new funding awards with an estimated total annual budget of more than $13 million, resulting in a total of 173 active grants. CDNM’s FY18 total research expenditures were $51 million.